Rchr
J-GLOBAL ID:200901088741420670   Update date: Oct. 29, 2024

SHIBUYA Akira

シブヤ アキラ | SHIBUYA Akira
Affiliation and department:
Job title: Professor
Research field  (2): Hematology and oncology ,  Immunology
Research keywords  (1): 免疫学・血液学
Research theme for competitive and other funds  (29):
  • 2019 - 2020 免疫受容体の機能解析
  • 2018 - 2020 虚血ストレスによる炎症誘導機構の解明とその制御
  • 2016 - 2020 The regulatory mechanisms of innate immune responses by inhibitory immunoreceptors
  • 2016 - 2016 Development of the therapy for allergic airway hypersensitivity by using a phospholipid liposome
  • 2015 - 2016 粘膜上皮ダイイングコードによる炎症応答制御機構の解明
Show all
Papers (375):
  • T, nabekura, S, Matsuo, SHIBUYA, Akira. Concanavalin-A-Induced Acute Liver Injury in Mice. CURRENT PROTOCOLS. 2024. 4. 8
  • Deborah, Elfira Amalia, Nabekura, Tsukasa, Shibuya, Kazuko, Shibuya, Akira. THEMIS2 impairs anti-tumor activity of NK cells by suppressing activating NK receptor signaling. Journal of Immunology. 2024
  • Y-H, Lin, S, Tahara-Hanaoka, N, Obana, S, Fukuda, Shibuya, Akira. An inhibitory immunoreceptor Allergin-1 regulates the intestinal dysbiosis and barrier function in mice. INTERNATIONAL IMMUNOLOGY. 2024. 36. 7. 365-371
  • S, Tahara, G, Okumura, T, Matsuo, Shibuya, Akira, K, Shibuya. Essential role of CD155 glycosylation in functional binding to DNAM-1 on natural killer cells. INTERNATIONAL IMMUNOLOGY. 2024. 36. 6. 317-325
  • Y-H., Lin, S, Tahara-Hanaoka, Shibuya, Akira. Human basophils promote IgE-dependent oral allergen-induced anaphylaxis in humanized mice. ALLERGOLOGY INTERNATIONAL. 2023. 73. 2. 345-347
more...
Patents (6):
  • ACTIVITY MODULATOR, MEDICINAL AGENT COMPRISING SAME, USE OF CD300A GENE-DEFICIENT MOUSE, AND ANTI-CD300A ANTIBODY
  • Graft-versus-host disease predictingmarker and use thereof
  • 移植片対宿主病予知マーカーおよびその利用
  • 移植片対宿主病予知マーカーおよびその利用
  • 移植片対宿主病予知マーカーおよびその利用
more...
Books (4):
  • 食品免疫学事典
    日本食品免疫学会 2021
  • Neuro-Oncology Advances
    2021
  • Keynote RA rheumatic & Autoimmune deseases
    2017
  • 臨床免疫・アレルギー科
    2014
Lectures and oral presentations  (531):
  • DNAM-1 exacerbates intestinal inflammation by activating ILC3 via the Akt/mTORC1/HIF-1α signaling pathway
    (第53回日本免疫学会学術集会)
  • Protective role of type I innate lymphoid cells from microbial infection
    (International Congress of Microbiology and Infectious Diseases)
  • Tumor-derived soluble CD155 inhibits DNAM-1-mediated tumor immunity
    (AVD IMMUNOLOGY 2024 CONFERENCE 2ND EURO-GLOBAL SUMMIT)
  • THEMIS2 impairs antitumor activity of NK cells by suppressing activating NK receptor signaling
    (The 1st Annual Meeting of the Japanese Cytokine Society)
  • CD300a immunoreceptor exacerbates heart injury and adverse remodeling after myocardial infarction and reperfusion in mice
    (第88回日本循環器学会学術集会)
more...
Education (1):
  • - 1981 Hokkaido University Faculty of Medicine
Work history (16):
  • 2012/04 - 現在 筑波大学 若手研究者育成推進委員会委員長
  • 2011/10 - 現在 University of Tsukuba Faculty of Medicine
  • 2014/04 - 2021/03 University of Tsukuba Life Science Center of Tsukuba Advanced Research Alliance (TARA)
  • 2013/04 - 2020/03 University of Tsukuba
  • 2011/04 - 2016/03 筑波大学 若手研究者育成推進委員会委員長
Show all
Committee career (33):
  • 2019/01 - 2022/12 日本免疫学会 評議員
  • 2018/01 - 2020/12 日本免疫学会 日本免疫学会設立50周年記念事業実行委員会委員
  • 2004/01 - 2020/12 日本血液学会 評議員
  • 2018/09 - 2020/08 日本血液疾患免疫療法学会 理事
  • 2015/04 - 2020/03 東京医科歯科大学 非常勤講師
Show all
Awards (14):
  • 2020/04 - 科学技術分野の文部科学大臣表彰(研究部門)
  • 2020/02 - 筑波大学Best Faculty Member
  • 2015/11 - 一般財団法人 茨城県科学技術振興財団 つくば賞
  • 2012/03 - 上原記念生命科学財団特定研究奨励賞
  • 2009/02 - 財団法人 高松宮妃癌研究基金 高松宮妃癌研究基金研究奨励賞
Show all
Association Membership(s) (7):
Japanese Society of Immunotherapy for Hematological Disorders ,  The Japanese Cancer Association ,  American Association of Immunologists ,  JAPANESE SOCIETY FOR IMMUNOLOGY ,  THE JAPANESE SOCIETY OF HEMATOLOGY ,  THE JANPANESE SOCIETY OF INTERNAL MEDICINE ,  日本学術会議連携会員
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page